A magnolol/BMSC-integrated collagen hydrogel with dual anti-inflammatory and regenerative functions for corneal repair
Biomaterials Advances · 2026-08 · 185 · 214865
DOI: 10.1016/j.bioadv.2026.214865 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Advances, 2026-08. Verfasst von Xiaojie Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Aier Academy of Ophthalmology, Central South University, No.188, Furong South Road, Tianxin District, Changsha, 410004, Hunan, PR China. Hauptthemen laut MEDLINE: Lignans, Hydrogels, Mesenchymal Stem Cells, Collagen. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Corneal injuries remain a major cause of visual impairment, where inflammation, infection, and stromal scarring severely hinder functional regeneration. Here, we propose a multifunctional hydrogel concept that integrates structural biomimicry with immunoregulatory and antimicrobial therapy to achieve scar-free corneal healing. The injectable hydrogel is constructed from type I collagen and oxidized dextran via dynamic Schiff-base crosslinking, incorporating poly(lactic-co-glycolic acid)-poly(ethylene glycol) (PLGA-PEG) nanomicelles encapsulating magnolol (Mag-NMs) and bone marrow-derived mesenchymal stem cells (BMSCs). This composite system exhibits excellent transparency, tunable viscoelasticity, and enzymatic biodegradability, forming a biocompatible microenvironment that supports cell integration and drug release. Mag-NMs endow potent antibacterial and anti-angiogenic properties while modulating macrophage polarization toward an anti-inflammatory M2 phenotype. Meanwhile, embedded BMSCs further promote epithelial repair and suppress fibrotic remodeling. In a rabbit corneal injury model, the OC/Mag-NMs/BMSCs hydrogel accelerated re-epithelialization, restored optical clarity, and markedly reduced inflammatory (IFN-γ, CD4, CD68) and fibrotic responses without systemic toxicity. This multi-targeting strategy demonstrates that coupling small-molecule nano-delivery with stem-cell therapy within a biomimetic scaffold enables comprehensive regulation of infection, inflammation, and fibrosis, offering a promising direction for translational corneal regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aier Academy of Ophthalmology, Central South University, No.188, Furong South Road, Tianxin District, Changsha, 410004, Hunan, PR China.
- Aier Eye Hospital, Jinan University, No.191, Huanshi Middle Road, Yuexiu District, Guangzhou, Guangdong, PR China.
- Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Guangdong Provincial Engineering and Technological Research Centre for Drug Carrier Development, Department of Biomedical Engineering, Jinan Unive…
- Aier Academy of Ophthalmology, Central South University, No.188, Furong South Road, Tianxin District, Changsha, 410004, Hunan, PR China; Aier Eye Hospital, Jinan University, No.191, Huanshi Middle Road, Yuexiu District,…
Zitieren
APA
Li, X., Feng, H., Feng, L., Ling, H., Song, X., Liang, W., Guo, R., & Yu, X. (2026). A magnolol/BMSC-integrated collagen hydrogel with dual anti-inflammatory and regenerative functions for corneal repair. Biomaterials Advances, 185, 214865. https://doi.org/10.1016/j.bioadv.2026.214865
Vancouver
Li X, Feng H, Feng L, Ling H, Song X, Liang W, et al. A magnolol/BMSC-integrated collagen hydrogel with dual anti-inflammatory and regenerative functions for corneal repair. Biomaterials Advances. 2026;185:214865. doi:10.1016/j.bioadv.2026.214865
BibTeX
@article{Li2026,
author = {Li, Xiaojie and Feng, Haitong and Feng, Longbao and Ling, Hanming and Song, Xi and Liang, Weiqi and Guo, Rui and Yu, Xiaoyi},
title = {A magnolol/BMSC-integrated collagen hydrogel with dual anti-inflammatory and regenerative functions for corneal repair},
journal = {Biomaterials Advances},
year = {2026},
volume = {185},
pages = {214865},
doi = {10.1016/j.bioadv.2026.214865}
}
EUVIMED